Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Crisafulli

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Reumatismo|February 13, 2025
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseasesChiara Crotti, Nicola Ughi, Emanuela Beretta, et al.
Biomedicines|July 2, 2021
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid AntibodiesCecilia Nalli, Daniele Lini, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|October 24, 2025
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Scientific Reports|October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosusAlessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Internal and Emergency Medicine|October 6, 2023
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease RegistryMartina D'Onghia, Elisa Cinotti, Alessandra Cartocci, et al.
Frontiers in Medicine|August 4, 2022
Development and implementation of the AIDA international registry for patients with Schnitzler's syndromeJurgen Sota, Antonio Vitale, Ewa Więsik-Szewczyk, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Reumatismo|February 13, 2025
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseasesChiara Crotti, Nicola Ughi, Emanuela Beretta, et al.
Biomedicines|July 2, 2021
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid AntibodiesCecilia Nalli, Daniele Lini, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|October 24, 2025
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
American Journal of Hematology|December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohortCarmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Scientific Reports|October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosusAlessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Internal and Emergency Medicine|October 6, 2023
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease RegistryMartina D'Onghia, Elisa Cinotti, Alessandra Cartocci, et al.
Frontiers in Medicine|August 4, 2022
Development and implementation of the AIDA international registry for patients with Schnitzler's syndromeJurgen Sota, Antonio Vitale, Ewa Więsik-Szewczyk, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Pageof 6